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The aim of our experimental work was to study whether carvedilol is able to protect renal tissue from cyclosporine toxic effect in animal model of cyclosporine nephropathy. The study was performed on twenty Wistar rats divided in two experimental groups: control (treated with placebo) and carvedilol (treated with p.o. dose 10mg/kg/day in 1 ml solution). Cyclosporine in oral dose of 15 mg/kg/day was administered to all animals during 15 days of experiment. Urine was collected daily for the assessment of diuresis, proteinuria, and determination of urea and creatinine levels. Serum collected at the end of the experiment (day 15) was used for the determination of urea and transferrin levels. The level of renal tissue damage was evaluated by the Jones method for basal membranes, glomeruli and tubuli impregnation, and by the Kossa method for calcium impregnation. For the determination of paranuclear inclusions presence we used chromanilinblue (CAB) method. Statistically significant differences between total protein levels in urine on day 7 of the experiment and urea levels in serum at the end of the experiment in the control group and the carvedilol-treated group indicate a protective effect of carvedilol on renal tissue, which is supported also by the results of a histological examination of renal tissue. Significant increase in the serum transferrin level was registered in the carvedilol-treated group and no significant changes were noted in ceruloplasmin serum levels. In conclusion, our pilot study showed that carvedilol has the ability to protect renal tissue from cyclosporine induced nephropathy in rats.
Carvedilol, cyclosporine nephropathy, antioxidative effect, histological examination
Carvedilol -(R/S)-1-(9H-Carbazol-4-yloxy)-3-(2-methoxy-benzylamino)-propan-2-ol is a cardiovascular drug with a wide therapeutic potential. It is a non selective blocker of α 1 and β-adrenergic receptors without intrinsic sympathomimetic activity, with membrane stabilising effects. Carvedilol, commonly used in therapy of hypertension and in patients with blood failure (Bultas 1998) combines several important pharmacological properties in one molecule. Beside the above mentioned effects, it also exerts an antioxidant potential, which was described in experiments both in vitro and in animal models. In a culture of endothelial cells, carvedilol protects from cell damage induced by oxygen radicals (Kumar et al. 2000; Ma et al. 1996) . Carvedilol also has the ability to trap superoxid and hydroxyl radicals in both aqueous and lipid environment and interferes with the atherogenesis process (Ma et al. 1996) . Because of its capability to trap free oxygen radicals (FOR), it inhibits oxidation of low density lipoproteins (LDL) and thus inhibits oxidized LDL formation and development of atherosclerotic plaque (Bultas 1998; Silbernagl and Lang 1998; Asbrink et al. 2000) . Moreover, this compound mitigates the unfavourable effect of ischemia and successive reperfusion, where supposedly its ability to scavenge FOR, restore myocardial blood flow by vasodilatation, protect endothelial functions, inhibit adhesion and activation of polymorphonuclears and protect from accumulation of lipids in the aorta wall is exerted (Bultas 1998; Ma et al. 1996) . Carvedilol was tested in conditions of the burn syndrome (Neãas et al. 2001 ) and alloxan diabetes (Barto‰íková et al. 1998) ; propitious effect was most notable in proximal renal tubules, where it decreased the disintegration of tubular epithelia and inhibited development of oedematous changes. The antioxidant effect of carvedilol protects kidneys from gentamicin induced nephrotoxicity, reduces creatine clearance, proteinuria and increase of serum urea and creatinine, and it also limits development of glomerulosclerosis (Kumar et al. 2000) .
In cyclosporine-induced nephrotoxicity, toxic effect of cyclosporine is given connected with oxidative stress (PecháÀ and Dobi‰ová 2003) . Cyclic undecapeptide cyclosporine A is used in the immunosuppressive treatment of patients after organs transplantation and in some autoimmune diseases (Lüllmann et al. 2004 ). The aim of our experimental work within preclinical tests of carvedilol antioxidative effects was to elicit whether this compound is able to protect renal tissue from cyclosporine toxic effect in the animal model of cyclosporine nephropathy.
Materials and Methods
For the purpose of this study we used 20 laboratory Wistar rats, male gender, of the same age and weight 208 ± 15 g. The animals came from a conventional breeding colony (Faculty of Medicine, Masaryk University, Brno) and were housed under standard conditions (temperature 20-24 °C, humidity 40-60 %, 12:12 L:D cycles with lighting up to 200 lux maximum). Cyclosporine (Sandimmun ® sol., Novartis International AG, Basel, Switzerland) at a dose of 15 mg/kg/day was administered per os (p. o.) to all animals during 15 days of experiment. Animals were divided in two experimental groups: 1 st group -control: treated with placebo -p.o. dose 1 ml of 0.9 % NaCl /day 2 nd group -carvedilol: treated with p.o. dose 10mg/kg/day (in 1 ml solution)
During the experiment the animals were placed separately in metabolic boxes, fed a standard diet (Diet for small laboratory animals M 1 ) and given water ad libitum. Urine was collected daily for the assessment of diuresis, proteinuria, and determination of urea and creatinine levels. Immediately after the end of the experiment, animals were euthanized by exsanguination, and blood was prepared for biochemical examination. Serum was used for the determination of urea and transferrin levels. Biochemical evaluation was realised on the automatic analyser Hitachi ® with commercial kits of the BioVendor company (Brno, Czech Republic).
Samples of renal tissue were taken for histopathological examination. The level of renal tissue damage was evaluated by the Jones method for basal membranes, glomeruli and tubuli impregnation, and the Kossa method for calcium impregnation. For the determination of paranuclear inclusions presence we used the chromanilinblue (CAB) method, which represents blue trichrom modified method (according to Department of Pathology and Anatomy, St. Anna Faculty Hospital methodology).
CAB (chromanilinblue) method: 1. Weigert hematoxilin 2. 1% phosphomolybden acid 3. CAB mixture (anilin blue 0,5g/100 ml, chromotrop 2R (Fluka) 2g), in distilled water, pH 1.05 (using HCl conc.)
The methodology of this study was approved by the Central Committee for Animal Protection and monitored by the Ethical Committee of the University of Veterinary and Pharmaceutical Sciences Brno.
The Stat Plus ® program was used for the statistical evaluation; values were compared by an unpaired t-test. Values with p < 0.05 were considered significant.
Results and Discussion
Hydrogen peroxide is toxic to the glomerular and tubulointerstitial renal system either directly or through the hydroxyl radical formation which is catalyzed by iron. In physiological conditions cells form hydrogen peroxide, but it is easily trapped by antioxidizing systems. When cyclosporine is administered, renal tissue is exposed to oxidative stress where antioxidizing systems are depleted. FOR and lipid peroxidation importantly participate in development of nephrotoxicity in patients taking cyclosporine A (Kumar et al. 2000) . It is assumed that FOR are not formed directly from cyclosporine A molecule, but their formation is conditioned by the involvement of cell enzymatic systems (Kumar et al. 2000) . Outcomes of biochemical examination and histological findings confirm the induction of cyclosporine nephropathy in our experiment in the control group of rats by administration of cyclosporine A at the dose of 15 mg/kg/day, as shown by statistically significant differences (p < 0.01 and p < 0.05) between levels of total protein in urine observed in the control group on days 7 and 15 of the experiment compared with day 2 (Table 1) , and medium-severe insult of renal proximal tubules epithelia in the control group (Plate III, Fig. 1 ). Morphologic signs of cyclosporine nephrotoxic effect are marked in proximal tubules. In epithelial cytoplasm, large vacuoles of the same size are formed (isometric vacuolization). In histological sections cytoplasm shows a bright pattern and swelling. Formation of paranuclear inclusions is also detectable by the CAB methodology. It is a blue trichom modified method, used in section examination of e.g. hepatic biopsy. Paranuclear inclusion formation is explained by a marked enlargement of plasmatic organelles, mitochondria in particular.
FOR are very reactive, have very short half-life and in most cases act at the point of origin. If scavengers of FOR are supposed to be effective, they must be present in the place of FOR activity. Carvedilol is partially eliminated by kidneys that guarantee its presence in point of FOR origin and activity (Jonsson et al. 1999) . Lipid peroxidation seriously impairs membrane functions, modifies membrane fluidity, participates in its disintegration associated with calcium ions transfer in cytoplasm, decreases membrane potential and allows membrane permeability for ions (·típek 2000). In the course of oxidizing stress, carvedilol protects from the collapse of plasmatic membrane, cell lyses and its subsequent death, impairment of lysosomes and cell nucleus, and maintains the structural and functional integrity of mitochondria (Santos and Moreno 2001) . Statistically significant differences (p < 0.05) between total protein levels in urine on day 7 of the experiment (Table 1) and urea levels in serum at the end of the experiment (Table 2) in the control group and the carvedilol treated group indicate a protective effect of carvedilol on renal tissue. Also the results of our histological examination of renal tissue in carvedilol-treated group show its protective effect (Plate III, Fig. 2 ).
In our experiment we registered a significant increase in the serum transferrin level in the carvedilol-treated group (Table 3) . Some studies do not put down the attenuation ability of carvedilol on lipoperoxidation and LDL oxidation to its scavenger activity, but to its ability to trap ferric ions. These ions are inactivated by binding with a molecule of carvedilol and Significant differences between levels of total protein in urine were observed in the control group on days 7 and 15 of experiment, compared with day 2 at the level of * p < 0.05 and ** p < 0.01, respectively. Statistically significant differences between levels of total protein in urine were observed in the control group and the carvedilol-treated group on day 7 at the level of * p < 0.05. Table 2 . Urea values assessed in serum of rats at the end of experiment urea [mmol/l] in serum control 9.62 ± 1.9 carvedilol 7.50 ± 1.6* Significant differences between levels of urea in serum were observed in the control group and the carvedilol-treated group at the level of * p < 0.05.
cannot take part in radical reactions and insult tissue (15). Ceruloplasmin is blood protein partaking in the copper transfer in system plasma, which is probably important for plasmatic Fe 2+ oxidation; however only little of copper-bounded ceruloplasmin is transferred in tissues (Silbernagl and Lang 1998). Because part of the carvedilol protective effect is likely to be associated with its ability to bind iron, but not copper ions, we could assume that the increase in the ceruloplasmin serum level in the carvedilol-treated group would not be present. Hence, our experiment did not show statistically significant differences between levels of serum ceruloplasmin in the control group and the carvedilol-treated group (Table 4) .
Concluding our results, we can say that cyclosporine administered at the mentioned doses leads to an experimentally induced nephropathy model in rats, which can be applied to determine a possible protective effect of various substances to tissue damage. In our pilot study carvedilol demonstrated the ability to protect renal tissue of Wistar rats from cyclosporine-induced nephropathy. This ability can be documented by results of biochemical and histological examination. This suggests the conclusion that the protective effect of carvedilol is of great importance in cyclosporine induced nephropathy and this effect might be utilised also in clinical use.
Protektivní efekt carvedilolu na modelu cyclosporinové nefropatie u potkanÛ
Cílem na‰í experimentální práce bylo v rámci preklinického testování antioxidaãních vlastností karvedilolu zjistit, zda má tato látka schopnost protektivnû pÛsobit na ledvinovou tkáÀ pfii modelu cyklosporinové nefropatie. Pokus byl proveden na dvaceti laboratorních potkanech kmene Wistar, rozdûlen˘ch do dvou skupin: kontrolní, které bylo podáno placebo 1 ml NaCl 0.9 % p.o./den, a skupiny léãené karvedilolem v dávce10mg/kg/den p.o. (v 1 ml roztoku).V‰em zvífiatÛm byl p.o. aplikován cyklosporin v dávce 15 mg/kg/den po celou dobu pokusu (15 dní). Dennû byla odebírána moã, stanovena diuréza, provedeno vy‰etfiení proteinurie, stanovení hladiny moãoviny a kreatininu. Sérum, získané na konci experimentu, bylo pouÏito pro vy‰etfiení hladiny moãoviny a transferinu. Pro histopatologické vy‰etfiení byla odebrána ledvinná tkáÀ, pro posouzení stupnû po‰kození ledvinné tkánû byla pouÏita metodika Jonesova na impregnaci bazálních membrán, glomerulÛ a tubulÛ, metodika Kossa na prÛkaz vápníku, a hodnocena pfiítomnost paranukleárních inkluzí barvením metodou CAB (chromanilinblue). Statisticky v˘znamn˘ rozdíl hodnot celkové bílkoviny v moãi 7. den trvání pokusu a hladiny moãoviny v séru mezi skupinou léãenou karvedilolem a skupinou kontrolní potvrzují protektivní úãinek karvedilolu na ledvinou tkáÀ, kter˘ je vyjádfien i v˘sledky histologického vy‰etfiení ledvinné tkánû. Bylo pozorováno statisticky 88 
